Table 5.
Concomitant therapies reported in studies. Italics indicates the wording used in the reports.
| Study (ref) | Antiviral agents | Antibiotic agents | Glucocorticoids | Transfusion based interventions | Other interventions |
|---|---|---|---|---|---|
| (Leng)23 | None | None | None | None | None |
| (Shu)24 | Abidor/ Oseltamivir |
Moxifloxacin | Yes | None | None |
| (Meng)25 | Lopinavir/ Ritonavir |
None | Yes | None | None |
| (Shi)26 | Antiviral drugs | Antibiotics | Yes | None | None |
| (Xu)27 | Antiviral therapy | Antibacterial treatment | None | Extracorporeal blood purification system | Multiple* |
| (Wei)28 | Arbidol, Lopinavir– Ritonavir |
None | Yes | None | None |
| (Zhu)29 | α-Interferon, Ribavirin, Ganciclovir | Moxifloxacin, Piperacillin tazobactam, Levofloxacin | Yes | None | None |
| (Lanzoni)30 | BAT | BAT | BAT | BAT | BAT |
| (Dilogo)31 | Oseltamivir | Azithromycin | None | None | None |
| (Haberle)32 | None | None | Yes | None | Multiple** |
| (Adas)33 | Favipiravir, HCQ |
Piperacillin-tazobactam, | Yes | None | Enoxaparin |
Includes hormone, gut microflora modulator, Chinese medicine treatment, basic disease medication.
Includes immunosuppressive medication, ACE inhibitor, AT1 receptor blocker, beta-blocker, other antihypertensive drugs, Calcium antagonists, antiplatelet drugs.
Abbreviations: BAT, best available therapy; HCQ, hydroxychloroquine.